Yunnan Baiyao and others set up the equity fund of TCM Big Health Innovation. The enterprise search APP shows that recently, Yunnan TCM Big Health Innovation Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 7 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the enterprise is jointly held by Yunnan Baiyao and BOC International Investment Co., Ltd., a wholly-owned subsidiary of BOC Securities.Marubi Co., Ltd. changed its name to Marubi Bio, and Marubi Co., Ltd. officially changed its name to Marubi Bio (603983.SH). This name change has been approved by Shanghai Stock Exchange and announced.Dale New Materials: Some products of subsidiary Daihua are applied in Huawei's supply chain system. Some investors asked Dale New Materials (300700) on the interactive platform: Have the company's products been applied in Huawei now? Daile New Materials replied that some products of Daihua, a subsidiary of the company, are applied in its supply chain system. For example, related products are applied in the processing of glass-ceramic panels of the latest mobile phones, and the current sales volume is relatively small.
NFL Miami Dolphins officially won the strategic investment from Cai Chongxin. On December 11th, local time, Miami Dolphins and stephen ross, Chairman of the Board of Directors, announced the strategic investment from Ares Management funds(Ares) and Brooklyn Nets owners Cai Chongxin and Oliver Weisberg. In addition to the Miami Dolphins, the deal also includes iconic assets such as Hard Rock Stadium and F1 Miami Grand Prix. Ares will get 10% of the shares, while Cai Chongxin and weisberg will jointly hold 3% of the shares, and the final agreement has yet to be completed. The NFL (National Football League) approved the sale of the minority non-controlling interest of the Dolphins at the league meeting that day. The transaction is expected to be completed in the next few days.FTSE China A50 index futures opened 0.13% higher, and closed down 0.01% in the last session.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.
The Hang Seng Index and Hang Seng Science and Technology Index both fell, while Meituan (03690.HK), Xpeng Motors (09868.HK) and JD.COM (09618.HK) all fell more than 2%.Yunnan Baiyao and others set up the equity fund of TCM Big Health Innovation. The enterprise search APP shows that recently, Yunnan TCM Big Health Innovation Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 7 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the enterprise is jointly held by Yunnan Baiyao and BOC International Investment Co., Ltd., a wholly-owned subsidiary of BOC Securities.The newly established enterprise management company in Erdos includes corporate headquarters management business. The enterprise search APP shows that recently, Ordos Dongyu Enterprise Management Co., Ltd. was established, with the legal representative of Chen Houbao and the registered capital of 20 million yuan. Its business scope includes: corporate headquarters management; Technical service, technical development, technical consultation, technical exchange, etc. Enterprise survey shows that the company is wholly owned by Ordos.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14